EVOMMUNE, INC. (EVMN)

(90% Positive) EVOMMUNE, INC. (EVMN) Announces Enrollment Update for patients Due to Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment

ALAUNOS THERAPEUTICS, INC. (TCRT)

(10% Negative) ALAUNOS THERAPEUTICS, INC. (TCRT) Announces Delay in adjustment Trials for body fat percentage Due to Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

TOYOTA MOTOR CORP/ (TM)

Director Olcott George Cunningham 🟢 acquired 159 shares of TOYOTA MOTOR CORP/ (TM) at $16.71 Transaction Date: Jun 25, 2026 | Filing ID: 000663